InsidersTradesSigma
Explore the complete record of transactions filed by WEISER MICHAEL, Director. Director active across 1 companies, notably Iovance Biotherapeutics, INC.. In total, 1 disclosures have been logged. Total volume traded: €14k. The latest transaction was filed on 31 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Michael Weiser is a Board Member at Iovance Biotherapeutics, Inc. He brings valuable expertise in biotechnology. His role involves overseeing the company's strategies and ensuring compliance with industry standards. Michael contributes to strategic decision-making that influences innovation and growth at Iovance.